Understanding Branch Retinal Vein Occlusion

Branch retinal vein occlusion (BRVO) is a condition that affects blood flow in the retina and can lead to blurred or distorted vision.

The retina is a thin layer of tissue at the back of the eye that converts light into signals the brain interprets as vision. Like any organ in the body, the retina relies on a network of arteries and veins to deliver oxygen and nutrients and to remove waste products.

A branch retinal vein occlusion occurs when one of the smaller veins that drains blood from the retina becomes blocked. This blockage most commonly occurs at a location where a vein crosses an artery. Over time, systemic conditions such as high blood pressure, diabetes, and high cholesterol can cause arteries to stiffen and thicken. As the artery hardens, it can compress the nearby vein, disrupting normal blood flow.

When a vein becomes blocked, blood and fluid back up into the retina. This can lead to bleeding, swelling, and damage to retinal tissue—particularly if the blockage involves the macula, the central portion of the retina responsible for sharp, detailed vision. In addition, reduced blood flow can impair oxygen delivery to the retina, leading to retinal ischemia and further vision loss over time.

Symptoms of BRVO

Symptoms of branch retinal vein occlusion vary depending on the location and severity of the blockage.

Common symptoms include:

• Blurred vision or reduced clarity
• A dark or blank spot in the central vision (scotoma)
• Wavy or crooked lines (metamorphopsia)

In some cases, especially when the affected area is away from the macula, BRVO may cause few or no noticeable symptoms and may be discovered during a routine eye examination.

Why Swelling Is the Main Problem

The most common cause of vision loss in BRVO is macular edema, which is swelling of the retina due to fluid leakage from damaged blood vessels. When normal blood flow is disrupted, the retina releases a protein called vascular endothelial growth factor (VEGF). VEGF increases blood vessel permeability, allowing fluid to leak into the retinal tissue and causing swelling.

When blood flow is significantly reduced, the resulting lack of oxygen (retinal ischemia) can cause the retina to release even more VEGF. In these cases, VEGF can also stimulate the growth of abnormal blood vessels. These fragile vessels are prone to bleeding and can further threaten vision.

How Is a Vein Occlusion Diagnosed?

A branch retinal vein occlusion can be diagnosed using several methods. A retinal specialist typically begins with a dilated eye examination, which allows direct visualization of the retinal blood vessels and is often sufficient to make the diagnosis.

Depending on the findings, additional testing may be ordered to gather more detailed information, including:

• Optical coherence tomography (OCT): A specialized imaging test that provides cross-sectional images of the retinal layers and helps determine the presence and severity of retinal swelling.
• Fluorescein angiography: An imaging study performed using a fluorescent dye that highlights blood flow within the retinal vessels, helping to identify areas of blockage, leakage, or reduced circulation.

Based on these results, your retinal specialist may recommend initiating treatment with anti-VEGF injections.

Anti-VEGF Injections: How They Work

Anti-VEGF injections are the mainstay of treatment for vision loss caused by BRVO. These medications block the effects of VEGF, reducing fluid leakage, decreasing retinal swelling, and helping stabilize or improve vision.

The medication is delivered directly into the eye using a very fine needle. Although the idea of an eye injection can be intimidating, the procedure is quick and typically well tolerated. The eye is thoroughly numbed beforehand, and most patients experience little to no discomfort.

What to Expect From Treatment

Anti-VEGF therapy is usually not a one-time treatment. Most patients begin with monthly injections, with the schedule adjusted over time based on how the eye responds. Some patients require ongoing treatment for months or even years, while others are able to gradually extend the time between injections.

The primary goal of treatment is to reduce macular swelling in order to stabilize and, when possible, improve vision.

Many patients experience meaningful visual improvement. However, it is important to understand that anti-VEGF injections treat the swelling and abnormal blood vessel growth—not the original vein blockage itself. As a result, vision may not fully return to normal in every case. Even so, treatment is critical because it often prevents further vision loss and preserves remaining sight.

Are There Other Treatment Options?

In certain situations, additional treatments may be considered, including:

• Laser therapy, used selectively to reduce the risk of abnormal blood vessel growth
• Steroid injections or implants, which may be considered when macular swelling does not adequately respond to anti-VEGF therapy after multiple injections

Despite these alternatives, anti-VEGF injections remain the most commonly used and most effective treatment for macular edema associated with BRVO.

Managing Risk Factors

Because BRVO is closely linked to systemic health conditions, managing underlying risk factors is an important part of long-term care. In addition to regular visits with your retinal specialist, controlling blood pressure, blood sugar, and cholesterol levels can reduce the risk of further retinal damage and help protect the other eye.

A Reassuring Outlook

A diagnosis of branch retinal vein occlusion can be concerning, but today’s outlook is far better than it was even a decade ago. With prompt diagnosis, regular monitoring, and effective anti-VEGF treatment, many people maintain functional vision and continue their daily activities with minimal disruption.

If you notice sudden changes in your vision, do not ignore them. Early evaluation by an eye care professional can make a meaningful difference in preserving sight and achieving the best possible outcome.

If you have been diagnosed with a vein occlusion or are experiencing new visual distortion, our retina team is here to support you, answer your questions, and guide you toward the best possible care for your vision.